These findings were associated with a decline of epithelial cells indicating that this treatment triggers a strong stimulation of MHC-I expression and a drastic decrease of EPCAM positive SCLC cells (Fig. 7 e, i). Here, EPCAM is linked to small cell lung carcinoma.